Skip to main content
. Author manuscript; available in PMC: 2022 Aug 3.
Published in final edited form as: Pain. 2021 Oct 28;163(8):1479–1488. doi: 10.1097/j.pain.0000000000002529

Fig. 5.

Fig. 5

Whole-mount staining of calcitonin gene-related peptide (CGRP). (A) Validation of primary antibody against CGRP. Scale bar, 50 μm. (B) Representative projected images from whole-mount staining of facial skin behind the vibrissa pad within the infraorbital territory from mice with ION-CCI injected with capsaicin plus vehicle (CCI/cap/Veh) and or with capsaicin plus paclitaxel (CCI/Cap/PAC) as indicated. Scale bar, 200 μm. (C) Quantification of CGRP+ afferent terminals. *p<0.05 in Student’s t-test.